16th International AIDS Conference Toronto, Canada - August 13 - 18, 2006

WOMEN AND THE ‘3 BY 5’ INITIATIVE: A POLICY ANALYSIS

Int Conf AIDS. 2006 Aug 13-18;16 Abstract No. ThLB0503

H. Worth
University of New South Wales, National Centre in HIV Social Research, Sydney, Australia

BACKGROUND: In March 2006 the ‘3 by5’ initiative ended with an estimated 3 million on antiretroviral therapy, mnay of whom were women. But success of the initiative cannot be judged by numbers alone.

METHODS: The paper will use UN/WHO policy documents together with country reports for the June 2006 UNGASS to undertake a gender analysis of the initiative.

RESULTS: This paper will show that overall women fared poorly in the initiative for a number of reasons:

• The association of the roll-out with routine HIV testing assumed a reduction in HIV-related stigma and violence
• Making HIV a clinic-based routinised part of healthcare particularly in the antenatal setting exacerbates the view of women as solely child-bearers and therefore having fewer rights in their own person.

CONCLUSIONS: Stigma and discrimination against women are central to the fight against HIV not an adjunct to the acceleration of ART.

Download PDF of this abstract.

2006-08-13
ThLB0503

Copyright © 2006 - International AIDS Society (IAS). All information and content relating to the abstracts from the 16th International AIDS Conference, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.

AEGiS is a 501c(3) not-for-profit organization made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, GlaxoSmithKline, the National Library of Medicine, Roche / Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.